BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 24841868)

  • 1. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
    Wu X; Lin H; Li S
    BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
    Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
    Orsini RG; Verhoeven RH; Lemmens VE; van Steenbergen LN; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Cancer; 2015 Sep; 51(13):1675-82. PubMed ID: 26159248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
    World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
    Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
    Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.
    Winer J; Zenati M; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2014 May; 21(5):1456-62. PubMed ID: 24201745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
    Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
    Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
    Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
    J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum.
    Zhu L; Ling C; Xu T; Zhang J; Zhang Y; Liu Y; Fang C; Yang L; Zhuang W; Wang R; Ping J; Wang M
    Pathol Oncol Res; 2021; 27():1609800. PubMed ID: 34276258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.
    Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH
    Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
    Tung SY; Wu CS; Chen PC
    Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
    Korphaisarn K; Morris V; Davis JS; Overman MJ; Fogelman DR; Kee BK; Dasari A; Raghav KPS; Shureiqi I; Trupti M; Wolff RA; Eng C; Menter DG; Hamilton S; Kopetz S
    Br J Cancer; 2019 Sep; 121(6):505-510. PubMed ID: 31406299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
    Qiu MZ; Teng KY; Ruan DY; Li YH; Chen XQ; Pan ZZ; He YJ; Wan DS; Xu RH
    Ai Zheng; 2009 Jul; 28(7):743-8. PubMed ID: 19624903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
    Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
    Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma.
    Zhao Z; Yan N; Pan S; Wang DW; Li ZW
    Sci Rep; 2020 Aug; 10(1):14126. PubMed ID: 32839528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
    J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.
    Park HS; Jung M; Kim HS; Kim HI; An JY; Cheong JH; Hyung WJ; Noh SH; Kim YI; Chung HC; Rha SY
    Ann Surg Oncol; 2015 Jan; 22(1):224-31. PubMed ID: 25081339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.
    Sheng H; Wei X; Mao M; He J; Luo T; Lu S; Zhou L; Huang Z; Yang A
    BMC Cancer; 2019 Nov; 19(1):1071. PubMed ID: 31703713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.